Search results for "Hodgkin"

showing 10 items of 180 documents

Analysis of Metabolic Parameters Coming from Basal and Interim PET in Hodgkin Lymphoma

2018

Objective: Positron Emission Tomography (PET) with F-18-Fluoro-deoxy-glucose (FDG) emerged as a prognostic tool to predict treatment outcome in Hodgkin Lymphoma (HL). Moreover, a FDG-PET adapted strategy is currently assessed in clinical trial to minimize the toxic effect while maintaining the efficacy of treatment in HL. Purpose was to analyze the quantitative parameters to support the prognostic role of FDG-PET today based on the semi-quantitative Deauville 5-point Scale (D5-PS). Methods: This retrospective study included 53 patients diagnosed with advanced-stage HL between 2009 and 2014, enrolled in the PET response-adapted clinical trial HD 0607. FDG-PET was performed at baseline (PET0)…

Pathologymedicine.medical_specialtyChemothrapy; FDG PET; Hodgkin lymphoma; Metabolic parameters; Metabolic tumor volume; Prognostic value; Radiology Nuclear Medicine and Imagingbusiness.industryHODGkin lymphomaMetabolic tumor volume02 engineering and technology021001 nanoscience & nanotechnologyInterim pet03 medical and health sciencesBasal (phylogenetics)0302 clinical medicineNuclear Medicine and ImagingFDG PETmedicineHodgkin lymphomaRadiology Nuclear Medicine and imaging030212 general & internal medicineMetabolic parametersRadiology0210 nano-technologyNuclear medicinebusinessPrognostic valueChemothrapyCurrent Medical Imaging Reviews
researchProduct

Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-Hodgkin's lymphoma xenografts.

2010

Background Although multimodality treatment can induce high rate of remission in many subtypes of non-Hodgkin's lymphoma (NHL), significant proportions of patients relapse with incurable disease. The effect of human bone marrow (BM) mesenchymal stem cells (MSC) on tumor cell growth is controversial, and no specific information is available on the effect of BM-MSC on NHL. Methodology/Principal Findings The effect of BM-MSC was analyzed in two in vivo models of disseminated non-Hodgkin's lymphomas with an indolent (EBV− Burkitt-type BJAB, median survival = 46 days) and an aggressive (EBV+ B lymphoblastoid SKW6.4, median survival = 27 days) behavior in nude-SCID mice. Intra-peritoneal (i.p.) i…

Pathologymedicine.medical_specialtyStromal cellTransplantation HeterologousMice Nudelcsh:Medicinemesenchimal stem cellsMice SCIDMiceimmune system diseaseshemic and lymphatic diseasesmesenchymal stem cells non-Hodgkin's lymphoma.AnimalsHumansMedicinehuman lymphoma xenograft; mesenchimal stem cellsOncology/Hematological Malignancieslcsh:ScienceSCID MiceMultidisciplinaryHematology/Bone Marrow and Stem Cell Transplantationbusiness.industryLymphoma Non-HodgkinLymphoblastlcsh:RMesenchymal stem cellNon-Hodgkin's LymphomaMesenchymal Stem CellsHematopoietic Stem Cellsmedicine.diseaseCoculture TechniquesLymphomaNon-Hodgkin's lymphomaEndothelial stem cellTransplantationApoptosislcsh:QHematology/Lymphomas and Chronic Lymphoblastic LeukemiabusinessMesenchymal Stem Cells; SCID Mice; Non-Hodgkin's LymphomaResearch Articlehuman lymphoma xenograft
researchProduct

Pathobiology of Hodgkin Lymphoma

2010

Despite its well-known histological and clinical features, Hodgkin's lymphoma (HL) has recently been the object of intense research activity, leading to a better understanding of its phenotype, molecular characteristics, histogenesis, and possible mechanisms of lymphomagenesis. There is complete consensus on the B-cell derivation of the tumor in most cases, and on the relevance of Epstein-Barr virus infection and defective cytokinesis in at least a proportion of patients. The REAL/WHO classification recognizes a basic distinction between lymphocyte predominance HL (LP-HL) and classic HL (cHL), reflecting the differences in clinical presentation and behavior, morphology, phenotype, and molec…

Pathologymedicine.medical_specialtybusiness.industryMixed cellularityLymphocyteHematologyReview ArticleHistogenesismedicine.diseasePhenotypeVirusLymphomaPathobiologymedicine.anatomical_structurehemic and lymphatic diseasesmedicineHodgkin lymphomaDiseases of the blood and blood-forming organsRC633-647.5businessWho classificationHodgkin lymphoma; microenvironment.Hodgkin lymphomamicroenvironment.Advances in Hematology
researchProduct

Burkitt’s lymphoma in pregnant woman: Difficult management of a rare case

2020

Highlights • Burkitt’s lymphoma, an aggressive non-Hodgkin lymphoma, is extremely rare during pregnancy. • Lymphoma of the small intestine is often overlooked in the early stages of the disease. • We described a multidisciplinary approach, cesarean section with surgical intestinal exploration.

Pediatricsmedicine.medical_specialtyBurkitt’s lymphomaIntestinal involvementNauseaCase ReportDisease03 medical and health sciences0302 clinical medicineimmune system diseasesPregnancyhemic and lymphatic diseasesmedicineNon-Hodgkin lymphomaPregnancyBurkitt's lymphomabusiness.industryGestational agemedicine.diseaseLymphoma030220 oncology & carcinogenesisVomitingGestation030211 gastroenterology & hepatologySurgerymedicine.symptombusinessBurkitt's lymphomaInternational Journal of Surgery Case Reports
researchProduct

Topology of multiplex heterogeneous networks of Hodgkin-Huxley-type of models with bistability leading to stabilization stable equilibrium

2021

The dynamics of a multiplex heterogeneous networks of oscillators is studied. Two types of very similar models based on the Hodgkin-Huxley formalism are used as the basic elements of the network: the first one demonstrates bursting oscillations; the second one manifests bistability between bursting oscillations and stable equilibrium. Multiplex networks were developed and investigated, assuming more active communication between models with bistability. Different topologies of the networks are studied. It is shown that in this case it is enough to have one element with bistability in the subnetworks in order to stabilize the equilibrium state in the entire network.

PhysicsBistabilityThermodynamic equilibriumTopology (electrical circuits)MultiplexType (model theory)TopologyNetwork topologyHeterogeneous networkHodgkin–Huxley model2021 5th Scientific School Dynamics of Complex Networks and their Applications (DCNA)
researchProduct

Residential Exposure to PM2.5 Components and Risk of Childhood Non-Hodgkin Lymphoma in Denmark: A Nationwide Register-Based Case-Control Study

2020

In a recent study, we observed an increased risk of childhood non-Hodgkin lymphoma (NHL) associated with exposure to fine atmospheric particulate matter (PM2.5) and black carbon (BC). In this nationwide register-based case-control study, we focus on specific components of PM2.5 in relation to childhood NHL in Denmark (1981&ndash

Register basedMale010504 meteorology & atmospheric sciencesHealth Toxicology and MutagenesisChildhood Non-Hodgkin LymphomaDenmarkSecondary organic aerosolslcsh:Medicine01 natural sciencescomplex mixturesArticle03 medical and health scienceschemistry.chemical_compound0302 clinical medicineimmune system diseasesInterquartile rangehemic and lymphatic diseasesAir PollutionMedicineHumans030212 general & internal medicineChildsecondary inorganic aerosols0105 earth and related environmental sciencesAerosolsAir Pollutantsparticulate matter componentsSecondary organic aerosolsbusiness.industryLymphoma Non-Hodgkinlcsh:RPublic Health Environmental and Occupational HealthCase-control studyOdds ratiocarbonaceous particlesEnvironmental ExposureConfidence intervalCancer registryregister-based studychemistryCase-Control StudiesParticulate Matterbusinesschildhood Non-Hodgkin LymphomaDemographyEnvironmental MonitoringInternational Journal of Environmental Research and Public Health
researchProduct

Non-response bias as a likely cause of the association between young maternal age at the time of delivery and the risk of cancer in the offspring.

2003

Some epidemiological studies have shown an association between young maternal age at the time of delivery and risk of cancer in the offspring. In a recent German case-control study, there was a twofold increase in the leukaemia risk for children whose mothers were aged < 20 years at the time of delivery. As the prevalence of younger mothers among control families was particularly low, data on maternal age distributions for the general population of Germany were obtained in order to examine the representativeness of the control sample. Despite the excellent sampling frame based on data from complete and up-to-date population registries and a satisfactory response rate among controls ( approx…

RiskPediatricsmedicine.medical_specialtyEpidemiologyOffspringPopulationCentral Nervous System NeoplasmsNeuroblastomaBiasEpidemiologyMedicineHumansNon-response biaseducationSampling frameResponse rate (survey)education.field_of_studybusiness.industryLymphoma Non-HodgkinCase-control studyInfant NewbornPrecursor Cell Lymphoblastic Leukemia-LymphomaSample size determinationCase-Control StudiesSample SizePediatrics Perinatology and Child HealthFemalebusinessDemographyMaternal AgePaediatric and perinatal epidemiology
researchProduct

Ergodicity for a stochastic Hodgkin–Huxley model driven by Ornstein–Uhlenbeck type input

2013

We consider a model describing a neuron and the input it receives from its dendritic tree when this input is a random perturbation of a periodic deterministic signal, driven by an Ornstein-Uhlenbeck process. The neuron itself is modeled by a variant of the classical Hodgkin-Huxley model. Using the existence of an accessible point where the weak Hoermander condition holds and the fact that the coefficients of the system are analytic, we show that the system is non-degenerate. The existence of a Lyapunov function allows to deduce the existence of (at most a finite number of) extremal invariant measures for the process. As a consequence, the complexity of the system is drastically reduced in c…

Statistics and ProbabilityDegenerate diffusion processesWeak Hörmander conditionType (model theory)01 natural sciencesPeriodic ergodicity010104 statistics & probability60H0760J25FOS: Mathematics0101 mathematicsComputingMilieux_MISCELLANEOUSMathematical physicsMathematics60J60Quantitative Biology::Neurons and CognitionProbability (math.PR)010102 general mathematicsErgodicityOrnstein–Uhlenbeck processHodgkin–Huxley model[MATH.MATH-PR]Mathematics [math]/Probability [math.PR]Hodgkin–Huxley model60J60 60J25 60H07Statistics Probability and UncertaintyTime inhomogeneous diffusion processesMathematics - Probability
researchProduct

Therapy response evaluation of malignant lymphoma in a multicenter study: comparison of manual and semiautomatic measurements in CT.

2014

Purpose: Comparison of manual one-/bi-dimensional measurements versus semi-automatically derived one-/bi-dimensional and volumetric measurements for therapy response evaluation of malignant lymphoma during CT follow-up examinations in a multicenter setting. Materials and Methods: MSCT data sets of patients with malignant lymphoma were evaluated before (baseline) and after two cycles of chemotherapy (follow-up) at radiological centers of five university hospitals. The long axis diameter (LAD), the short axis diameter (SAD) and the bi-dimensional WHO of 307 target lymph nodes were measured manually and semi-automatically using dedicated software. Lymph node volumetry was performed semi-automa…

ThoraxAdultMalemedicine.medical_specialtyRadiation DosageMalignant lymphomaYoung AdultAntineoplastic Combined Chemotherapy ProtocolsImage Interpretation Computer-AssistedMultidetector Computed TomographyMedicineHumansRadiology Nuclear Medicine and imagingLymph nodeAgedNeoplasm StagingRetrospective StudiesAged 80 and overbusiness.industryLymphoma Non-HodgkinMediastinumRetrospective cohort studyMiddle Agedmedicine.diseaseHodgkin DiseaseLymphomamedicine.anatomical_structureTherapy responseTreatment OutcomeMulticenter studyFemaleRadiologybusinessRoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin
researchProduct

Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic st…

2017

IF 7.702; International audience; The survival of patients with diffuse large B-cell lymphoma has increased during the last decade as a result of addition of anti-CD20 to anthracycline-based chemotherapy. Although the trend is encouraging, there are persistent differences in survival within and between the USA and European countries suggesting that non-biological factors play a role. Our aim was to investigate the influence of such factors on relative survival of patients with diffuse large B-cell lymphoma. We conducted a retrospective, multicenter, registry-based study in France on 1165 incident cases of diffuse large B-cell lymphoma between 2002 and 2008. Relative survival analyses were p…

[SDV.MHEP.HEM] Life Sciences [q-bio]/Human health and pathology/HematologyMale0301 basic medicinePediatricsMultivariate analysisMESH: RegistriesMESH : AgedMESH: ComorbidityComorbidityMESH : Lymphoma Large B-Cell DiffuseMESH: Aged 80 and over0302 clinical medicineInternational Prognostic IndexMESH : ChildMESH: ChildMESH : Population Surveillance[ SDV.MHEP.HEM ] Life Sciences [q-bio]/Human health and pathology/HematologyMESH : FemaleRegistriesYoung adultChildAged 80 and overMESH: AgedMESH: Middle AgedMESH : PrognosisRelative survivalMESH: Patient Outcome Assessment[SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/HematologyArticlesHematologyMiddle AgedMESH : AdultPrognosisMESH : Patient Outcome Assessment3. Good healthMESH: Young AdultPopulation SurveillanceMESH: Survival Analysis030220 oncology & carcinogenesisMESH : ComorbidityMarital statusFemaleFranceLymphoma Large B-Cell DiffuseNon-Hodgkin LeukemiaAdultmedicine.medical_specialtyAdolescentMESH : MaleMESH: Factor Analysis StatisticalMESH : Young AdultMESH : Factor Analysis StatisticalMESH: PrognosisMESH: Population SurveillanceMESH: Social ClassYoung Adult03 medical and health sciencesMESH : AdolescentInternal medicineMESH : Social ClassmedicineHumansMESH : Middle AgedMESH : Aged 80 and overMESH : FranceSurvival analysisAgedMESH: AdolescentMESH: Humansbusiness.industryMESH : HumansMESH: Adultmedicine.diseaseSurvival AnalysisComorbidityMESH: MalePatient Outcome AssessmentMESH: France030104 developmental biologySocial ClassMESH: Lymphoma Large B-Cell DiffuseMESH : Survival AnalysisFactor Analysis StatisticalbusinessMESH: FemaleDiffuse large B-cell lymphomaMESH : RegistriesHaematologica
researchProduct